Cyclerion Therapeutics, Inc. - CYCN

About Gravity Analytica
Recent News
- 09.24.2025 - Pioneering a New Era in Neuropsychiatric Therapies
- 09.24.2025 - Pioneering a New Era in Neuropsychiatric Therapies
- 09.23.2025 - Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
- 09.23.2025 - Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
- 09.23.2025 - Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Recent Filings
- 09.23.2025 - EX-99.1 EX-99.1
- 09.23.2025 - 8-K Current report
- 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 06.18.2025 - 8-K Current report
- 05.15.2025 - EFFECT Notice of Effectiveness
- 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.13.2025 - CORRESP Correspondence
- 05.12.2025 - UPLOAD SEC-generated letter